Cavity frequency-dependent theory for vibrational polariton chemistry
Recent experiments show the management of chemical reactivities by coupling molecules inside an optical microcavity. In distinction, transition state theory predicts no change of the response barrier top throughout this course of. Here, we current a theoretical rationalization of the cavity modification of the bottom state reactivity within the vibrational robust coupling (VSC) regime in polariton chemistry. Our theoretical outcomes recommend that the VSC kinetics modification is originated from the non-Markovian dynamics of the cavity radiation mode that {couples} to the molecule, resulting in the dynamical caging impact of the response coordinate and the suppression of response charge fixed for a particular vary of photon frequency near the barrier frequency.
We use a easy analytical non-Markovian charge theory to explain a single molecular system coupled to a cavity mode. We show the accuracy of the speed theory by performing direct numerical calculations of the transmission coefficients with the identical mannequin of the molecule-cavity hybrid system. Our simulations and analytical theory present a believable rationalization of the photon frequency dependent modification of the chemical reactivities within the VSC polariton chemistry.
The impossibility of experiencing the molecular world with our senses hampers instructing and understanding chemistry as a result of very summary ideas (resembling atoms, chemical bonds, molecular construction, reactivity) are required for this course of. Virtual actuality, particularly when based mostly on express bodily modeling (probably in actual time), gives an answer to this dilemma. Chemistry instructing could make use of superior applied sciences resembling virtual-reality frameworks and haptic units.
We present how an immersive studying setting may very well be utilized to assist college students perceive the core ideas of typical chemical reactions by providing a way more intuitive method than conventional studying settings. Our setting depends on an interactive exploration and manipulation of a chemical system; this method is simulated in real-time with quantum chemical strategies, and subsequently, behaves in a bodily significant manner.
Simulation of the consequences of forest harvesting beneath altering local weather to tell long-term sustainable forest administration utilizing a biogeochemical mannequin
Process ecosystem fashions are helpful instruments to offer perception on advanced, dynamic ecological methods, and their response to disturbances. The biogeochemical mannequin PnET-BGC was modified and examined utilizing subject observations from an experimentally whole-tree harvested northern hardwood watershed (W5) on the Hubbard Brook Experimental Forest (HBEF), New Hampshire, USA. Modelling of the Cascadia and Kyushu subduction zones reveals that the merchandise of sediment melting carefully reproduce the magnetotelluric observations.
In this research, the confirmed mannequin was used as a heuristic device to analyze long-term adjustments in hydrology, biomass accumulation, and soil resolution and stream water chemistry for three completely different watershed slicing intensities and three rotation lengths beneath each fixed (present local weather) and altering future local weather situations and atmospheric CO2 via the yr 2200. For the no future slicing situation, complete ecosystem saved carbon (i.e., sum of aboveground biomass, woody particles and soil) reached a most worth of 207 t C ha-1 beneath fixed local weather however elevated to 452 t C ha-1 beneath altering local weather in 2200 as a consequence of a CO2 fertilization impact.
Harvesting of timber decreased complete ecosystem saved carbon between 7 and 36% for fixed local weather and 7-60% beneath altering local weather, respectively, with better reductions for shorter logging rotation lengths and better watershed slicing intensities. Harvesting beneath local weather change resulted in noticeable losses of soil natural matter (12-56%) coinciding with lack of soil vitamins primarily as a consequence of increased charges of soil mineralization related to will increase in temperature, in contrast with fixed local weather situations.
Cumulative stream leaching of nitrate beneath local weather change exceeded fixed local weather values for the varied slicing regimes. Under each local weather situations the mannequin projected better sensitivity to various the size of slicing interval than slicing intensities. Hypothetical mannequin simulations spotlight future challenges in sustaining long-term productiveness of managed forests beneath altering local weather as a consequence of a possible for a deterioration of soil fertility.
Melting of subducted sediments reconciles geophysical pictures of subduction zones
Sediments play a key function in subduction. They assist management the chemistry of arc volcanoes and the placement of seismic hazards. Here, we current a brand new mannequin describing the destiny of subducted sediments that explains magnetotelluric fashions of subduction zones, which generally present an enigmatic conductive anomaly on the trenchward aspect of volcanic arcs. In many subduction zones, sediments will soften trenchward of the supply area for arc melts. High-pressure experiments present that these sediment melts will react with the overlying mantle wedge to supply electrically conductive phlogopite pyroxenites.
Equine IL-1 alpha Recombinant Protein |
|||
R01144-3 | BosterBio | 5ug/vial | EUR 310.8 |
Description: IL-1 alpha (IL-1α, IL-1F1) is a member of the interleukin 1 family of cytokines. IL-1 alpha is an inflammatory cytokine active in the initiation of the inflammatory reaction and in driving Th1 and Th17 inflammatory responses. Equine IL-1 alpha Recombinant Protein is purified interleukin-1 alpha cytokine produced in yeast. |
Equine IFN alpha 1 Recombinant Protein |
|||
R09608-3 | BosterBio | 5ug/vial | EUR 310.8 |
Description: IFN alpha is a mammalian Type I inferferon, mainly involved in innate immune response against viral infection. Equine IFN alpha 1 Recombinant Protein is purified IFN alpha produced in yeast. |
Genorise® Recombinant Equine IFN alpha protein |
|||
GR104329 | Genorise Scientific | 5 µg | EUR 285 |
Recombinant (HEK) Hemagglutinin Influenza A Virus H3N8 (A/equine/Gansu/7/2008) HA protein (1-344, His-tag, >95%) |
|||
RP-1625 | Alpha Diagnostics | 10 ug | EUR 416.4 |
Butyrylcholine esterase (7U/mg), Equine Serum |
|||
BCE-02 | Alpha Diagnostics | 5 mU | EUR 562.8 |
Butyrylcholine esterase (50U/mg), Equine Serum |
|||
BCE-01 | Alpha Diagnostics | 5 mU | EUR 634.8 |
Horse IgA (Equine, control, non-immune), purified |
|||
20019-3-100 | Alpha Diagnostics | 100 ug | EUR 343.2 |
Recombinant Equine CCL11 |
|||
CCL11-138E | Creative BioMart | 25ug | EUR 318.4 |
Description: Stable for up to twelve months from date of receipt at -20°C. Stable for at least 3 months when stored in working aliquots with a carrier protein at -20°C. Avoid repeated freeze/thaw cycles. |
Equine TNF-α ELISA Kit |
|||
T106004 | 101Bio | 1 x 96-well | EUR 569 |
SAA Equine Recombinant |
|||
MBS313582-01mg | MyBiosource | 0.1mg | EUR 1175 |
SAA Equine Recombinant |
|||
MBS313582-5x01mg | MyBiosource | 5x0.1mg | EUR 5115 |
Recombinant Equine herpesvirus 1 Alpha trans-inducing factor 82 kDa protein (14), partial |
|||
MBS1123432-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Equine herpesvirus 4 Alpha trans-inducing factor 82 kDa protein (14), partial |
|||
MBS1060673-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Equine herpesvirus 1 Alpha trans-inducing factor 82 kDa protein (14), partial |
|||
MBS1323403-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Horse IgM (Equine, Whole IgM, control, non-immune), purified |
|||
20019-2 | Alpha Diagnostics | 100 ug | EUR 196.8 |
Recombinant Equine IFN-γ |
|||
QEIFP-0101 | Cyagen | 100ug | Ask for price |
Recombinant Equine IL-1β |
|||
QEILP-0101 | Cyagen | 10ug | Ask for price |
Horse IgG (Equine, Whole IgG, control, non-immune)-HRP Conjugate |
|||
20019-HP | Alpha Diagnostics | 0.5 mg | EUR 242.4 |
Recombinant Equine IL-1RA |
|||
QEILP-0102 | Cyagen | 5ug | Ask for price |
Horse IgG (Equine, Whole IgG, control, non-immune)-FITC Conjugate |
|||
20019-F | Alpha Diagnostics | 0.5 mg | EUR 242.4 |
Nori® Equine TNF-alpha POCT Systems-25 Tests |
|||
GR223023 | Genorise Scientific | 25 Tests | EUR 618 |
Horse IgM (Equine, Whole IgM, control, non-immune)-biotinylated, purified |
|||
20019-2-B | Alpha Diagnostics | 100 ug | EUR 242.4 |
Horse IgG (Equine, Whole IgG, control, non-immune)-biotinylated, purified |
|||
20019-B | Alpha Diagnostics | 0.5 mg | EUR 196.8 |
Recombinant Equine KITLG Protein |
|||
KITLG-4392E | Creative BioMart | 100 µg | EUR 1498.4 |
Description: Store at -20 centigrade. |
Recombinant Equine IL28B Protein |
|||
IL28B-4370E | Creative BioMart | 5 µg | EUR 398.4 |
Description: Store at -20 centigrade. |
Recombinant Equine PDGFB Protein |
|||
PDGFB-4410E | Creative BioMart | 25 µg | EUR 374.4 |
Description: Store at -20 centigrade. |
Horse IgG Fab fragment (Equine, Whole IgG, control, non-immune), purified |
|||
20019-1-Fab | Alpha Diagnostics | 0.5 mg | EUR 196.8 |
Equine CCL3 Recombinant Protei |
|||
R00405-1 | BosterBio | 5ug/vial | EUR 310.8 |
Description: Chemokine ligand 3 (CCL3), also known as Macrophage Inflammatory Protein-1 alpha (MIP-1 alpha), is a small cytokine belonging to the CC chemokine family. CCL3 (MIP-1 alpha) is a chemoattractant for several different leukocytes, with varying degrees of potency. Equine CCL3 Recombinant Protein is purified chemokine ligand 3 (CCL3, MIP-1 alpha) produced in yeast. |
Equine EPO Recombinant Protein |
|||
R00484-1 | BosterBio | 5ug/vial | EUR 310.8 |
Description: Erythropoietin (EPO) is an essential hormone for red blood cell production. Erythropoietin has a range of actions including vasoconstriction-dependent hypertension, stimulating angiogenesis, and inducing proliferation of smooth muscle fibers. Equine Erythropoietin Recombinant Protein is purified Erythropoietin (EPO) produced in yeast. |
Equine CCL5 Recombinant Protei |
|||
R00617-2 | BosterBio | 5ug/vial | EUR 310.8 |
Description: CCL5, also known as RANTES (regulated and normal T cell expressed and secreted), is a member of the C-C Chemokine Family. RANTES (CCL5) is chemotactic for T cells, eosinophils, and basophils, and plays an active role in recruiting leukocytes into inflammatory sites. Equine CCL5 Recombinant Protein is purified CCL5 (RANTES) produced in yeast. |
Horse IgG Fab2 fragment (Equine, Whole IgG, control, non-immune), purified |
|||
20019-1-Fab2 | Alpha Diagnostics | 0.5 mg | EUR 196.8 |
Recombinant Equine Interleukin-2 |
|||
cyt-738-1mg | ProSpec Tany | 1mg | EUR 2700 |
Recombinant Equine Interleukin-2 |
|||
cyt-738-20g | ProSpec Tany | 20µg | EUR 145 |
Recombinant Equine Interleukin-2 |
|||
cyt-738-5g | ProSpec Tany | 5µg | EUR 60 |
Recombinant Equine Interleukin-2 |
|||
MBS145623-0005mg | MyBiosource | 0.005mg | EUR 240 |
Recombinant Equine Interleukin-2 |
|||
MBS145623-002mg | MyBiosource | 0.02mg | EUR 310 |
Recombinant Equine Interleukin-2 |
|||
MBS145623-1mg | MyBiosource | 1mg | EUR 2880 |
Recombinant Equine Interleukin-2 |
|||
MBS145623-5x1mg | MyBiosource | 5x1mg | EUR 12630 |
Equine CCL2 Recombinant Protein |
|||
R00056-2 | BosterBio | 5ug/vial | EUR 310.8 |
Description: Chemokine (C-C motif) ligand 2 (CCL2), also known as monocyte chemotactic protein-1 (MCP-1), is a small cytokine belonging to the CC chemokine family. CCL2 (MCP-1) recruits monocytes, memory T cells, and dendritic cells to sites of tissue injury and infection. Equine CCL2 (MCP-1) Recombinant Protein is purified CCL2 (MCP-1) produced in yeast. |
Equine CXCL9 Recombinant Protein |
|||
R01397-1 | BosterBio | 5ug/vial | EUR 310.8 |
Description: CXCL9 (MIG) is a T-cell chemoattractant. Induced by IFN-gamma (IFN-γ), the ELR-negative chemokine CXCL9 (MIG) elicits its effects by binding to the cell surface chemokine receptor CXCR3. Equine CXCL9 Recombinant Protein is purified CXCL9 (MIG) produced in yeast. |
Equine CCL11 Recombinant Protein |
|||
R01438-1 | BosterBio | 5ug/vial | EUR 310.8 |
Description: Chemokine ligand 11 (CCL11) belongs to the CC chemokine family and is commonly known as Eotaxin-1. CCL11 (Eotaxin-1) selectively recruits eosinophils by inducing their chemotaxis, and therefore, is implicated in allergic responses. Equine CCL11 Recombinant Protein is purified chemokine ligand 11 (CCL11, Eotaxin-1) produced in yeast. |
Equine CXCL10 Recombinant Protein |
|||
R00278-2 | BosterBio | 5ug/vial | EUR 310.8 |
Description: The ELR-negative CXC chemokine CXCL10 (IP-10) has been attributed to several roles, such as chemoattraction for monocytes/macrophages, T cells, NK cells, and dendritic cells, promotion of T cell adhesion to endothelial cells, antitumor activity, and inhibition of bone marrow colony formation and angiogenesis. Equine CXCL10 Recombinant Protein is purified CXCL10 (IP-10) produced in yeast. |
Recombinant Equine Interferon-gamma |
|||
AP60276 | SAB | 500ug | EUR 885 |
Recombinant Equine Interferon-gamma |
|||
cyt-739-1mg | ProSpec Tany | 1mg | EUR 2700 |
Recombinant Equine Interferon-gamma |
|||
cyt-739-20g | ProSpec Tany | 20µg | EUR 145 |
Recombinant Equine Interferon-gamma |
|||
cyt-739-5g | ProSpec Tany | 5µg | EUR 60 |
Recombinant Equine Interferon-gamma |
|||
MBS146001-0005mg | MyBiosource | 0.005mg | EUR 240 |
Recombinant Equine Interferon-gamma |
|||
MBS146001-002mg | MyBiosource | 0.02mg | EUR 310 |
Recombinant Equine Interferon-gamma |
|||
MBS146001-1mg | MyBiosource | 1mg | EUR 2880 |
Recombinant Equine Interferon-gamma |
|||
MBS146001-5x1mg | MyBiosource | 5x1mg | EUR 12630 |
Recombinant Equine Interferon-gamma |
|||
P1397-.1 | ApexBio | 100ug | EUR 396 |
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Equine Interferon-gamma |
|||
P1397-.5 | ApexBio | 500ug | EUR 888.8 |
Description: Peptides & Proteins|Recombinant Proteins |
Interleukin-2 Equine Recombinant |
|||
rAP-0649 | Angio Proteomie | Inquiry | Ask for price |
Genorise® Recombinant Equine HGF |
|||
GR104207 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant Equine BNP |
|||
GR104274 | Genorise Scientific | 5 µg | EUR 285 |
TNF ELISA Kit (Equine) (OKEH04796) |
|||
OKEH04796 | Aviva Systems Biology | 96 Wells | EUR 433.2 |
Description: Description of target: Cytokine that binds to TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It is mainly secreted by macrophages and can induce cell death of certain tumor cell lines. It is potent pyrogen causing fever by direct action or by stimulation of interleukin-1 secretion and is implicated in the induction of cachexia, Under certain conditions it can stimulate cell proliferation and induce cell differentiation.The TNF intracellular domain (ICD) form induces IL12 production in dendritic cells.;Species reactivity: Equine;Application: ;Assay info: Assay Methodology: Quantitative Sandwich Immunoassay;Sensitivity: |
Genorise® Recombinant equine TLR1 |
|||
GR104008 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant equine TLR2 |
|||
GR104009 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant equine TLR3 |
|||
GR104010 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant equine TLR5 |
|||
GR104011 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant equine TLR7 |
|||
GR104012 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant equine TLR9 |
|||
GR104013 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant Equine VEGF |
|||
GR104209 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant Equine cTnT |
|||
GR104288 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant Equine cTnI |
|||
GR104289 | Genorise Scientific | 5 µg | EUR 285 |
Recombinant Equine IL-2 Cys141Ser |
|||
QEILP-0201 | Cyagen | 10ug | Ask for price |
Interferon-Gamma Equine Recombinant |
|||
rAP-0471 | Angio Proteomie | Inquiry | Ask for price |
Equine IL-13 Recombinant Protei |
|||
R00077-3 | BosterBio | 5ug/vial | EUR 310.8 |
Description: IL-13 is an important mediator of allergic inflammation and disease. In addition to effects on immune cells, IL-13 is implicated as a central mediator of the physiologic changes induced by allergic inflammation in many tissues. Equine IL-13 Recombinant Protein is purified interleukin-13 produced in yeast. |
Equine IL-6 Recombinant Protein |
|||
R00102-3 | BosterBio | 5ug/vial | EUR 310.8 |
Description: Interleukin-6 (IL-6) is an interleukin that acts as both a pro-inflammatory and anti-inflammatory cytokine. Equine IL-6 Recombinant Protein is purified interleukin-6 produced in yeast. |
Equine IL-4 Recombinant Protein |
|||
R00230-3 | BosterBio | 5ug/vial | EUR 310.8 |
Description: IL-4 has many biological roles, including the stimulation of activated B-cell and T-cell proliferation, and the differentiation of CD4+ T-cells into Th2 cells. It is a key regulator in humoral and adaptive immunity. Equine IL-4 Recombinant Protein is purified interleukin-4 produced in yeast. |
Equine IL-2 Recombinant Protein |
|||
R00387-3 | BosterBio | 5ug/vial | EUR 310.8 |
Description: Interleukin-2 (IL-2) is a cytokine produced by T-helper cells in response to antigenic or mitogenic stimulation. It is required for T-cell proliferation and other activities crucial to the regulation of the immune response. Equine IL-2 Recombinant Protein is purified interleukin-2 produced in yeast. |
Equine IL-8 Recombinant Protein |
|||
R00423-5 | BosterBio | 5ug/vial | EUR 310.8 |
Description: Interleukin-8 (IL-8), also known as CXCL8, is an ELR-positive CXC family member chemokine produced by macrophages and other cell types such as epithelial cells. ELR-positive CXC chemokines such as IL-8 specifically induce the migration of neutrophils, and interact with chemokine receptors CXCR1 and CXCR2. Equine IL-8 Recombinant Protein is purified interleukin-8 produced in yeast. |
Equine IL-5 Recombinant Protein |
|||
R01086-2 | BosterBio | 5ug/vial | EUR 310.8 |
Description: The IL-5 cytokine has a key role in regulating eosinophil development and is responsible for selective terminal differentiation of eosinophils. It is associated with the cause of several allergic diseases including allergic rhinitis and asthma. Equine IL-5 Recombinant Protein is purified interleukin-5 produced in yeast. |
Genorise® Recombinant Equine ProBNP |
|||
GR104275 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant Equine SLC2A1 |
|||
GR104287 | Genorise Scientific | 5 µg | EUR 285 |
Equine IL-10 Recombinant Protein |
|||
R00021-2 | BosterBio | 5ug/vial | EUR 310.8 |
Description: IL-10 is an anti-inflammatory cytokine and a member of the IL-10 family of cytokines, which have indispensable functions in many infectious and inflammatory diseases. Equine IL-10 Recombinant Protein is purified interleukin-10 produced in yeast. |
Equine IL-15 Recombinant Protein |
|||
R00212-1 | BosterBio | 5ug/vial | EUR 310.8 |
Description: Interleukin-15 (IL-15) is a cytokine with structural similarity to IL-2 that is secreted by mononuclear phagocytes following infection by virus(es). This cytokine induces cell proliferation of natural killer cells. Equine IL-15 Recombinant Protein is purified interleukin-15 produced in yeast. |
Nori® Equine (horse) TNF-alpha ELISA Kit-Urine |
|||
GR106016 | Genorise Scientific | 96-well | EUR 461 |
Equine VEGF-A Recombinant Protein |
|||
R00045-2 | BosterBio | 5ug/vial | EUR 310.8 |
Description: VEGF-A is member of the family of vascular endothelial growth factor (VEGF) proteins, which stimulate vasculogenesis and angiogenesis to restore oxygen supply to tissues. VEGF-A is also a vasodilator and increases microvascular permeability and was originally referred to as vascular permeability factor (VPF). Equine VEGF-A Recombinant Protein is purified vascular endothelial growth factor A produced in yeast. |
Equine IL-17A Recombinant Protein |
|||
R00421-2 | BosterBio | 5ug/vial | EUR 310.8 |
Description: IL-17A is a member of the IL-17 family of cytokines, whose members are involved in numerous immune regulatory functions. IL-17 induces the production of many other cytokines, chemokines, and prostaglandins. Equine IL-17A Recombinant Protein is purified interleukin-17A produced in yeast. |
Equine IL-1ra Recombinant Protein |
|||
R00651-4 | BosterBio | 5ug/vial | EUR 310.8 |
Description: Interleukin-1 Receptor Antagonist Protein (IL-1F3, IL-1ra) belongs to the IL-1 family of cytokines, whose members play key roles in the development and regulation of inflammation. IL-1 receptor antagonist (IL-1ra; IL-1F3) reduces inflammation by blocking the binding of the agonist receptor ligands. Equine IL-1 Receptor Antagonist Recombinant Protein is purified interleukin-1 receptor antagonist protein (IL-1F3, IL-1ra) produced in yeast. |
Equine GM-CSF Recombinant Protein |
|||
R00911-3 | BosterBio | 5ug/vial | EUR 310.8 |
Description: Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a protein secreted by macrophages, T cells, mast cells, NK cells, endothelial cells and fibroblasts. GM-CSF stimulates stem cells to produce granulocytes (neutrophils, eosinophils, and basophils) and monocytes. Equine GM-CSF Recombinant Protein is purified GM-CSF produced in yeast |
Nori Equine TNF RI/TNFRSF1A ELISA Kit |
|||
GR106480 | Genorise Scientific | 96-well | EUR 461 |
Recombinant (E.Coli) Human p38 alpha/SAPK2 alpha |
|||
RP-675 | Alpha Diagnostics | 1 ug | EUR 343.2 |
Recombinant Equine Interleukin-1 beta |
|||
AP60273 | SAB | 100ug | EUR 1398 |
Recombinant Equine Interleukin-1 beta |
|||
cyt-411-10g | ProSpec Tany | 10µg | EUR 145 |
Recombinant Equine Interleukin-1 beta |
|||
cyt-411-1mg | ProSpec Tany | 1mg | EUR 4680 |
Recombinant Equine Interleukin-1 beta |
|||
cyt-411-2g | ProSpec Tany | 2µg | EUR 60 |
Recombinant Equine Interleukin-1 beta |
|||
MBS142287-0002mg | MyBiosource | 0.002mg | EUR 240 |
Recombinant Equine Interleukin-1 beta |
|||
MBS142287-001mg | MyBiosource | 0.01mg | EUR 310 |
Recombinant Equine Interleukin-1 beta |
|||
MBS142287-1mg | MyBiosource | 1mg | EUR 4895 |
Recombinant Equine Interleukin-1 beta |
|||
MBS142287-5x1mg | MyBiosource | 5x1mg | EUR 21695 |
Recombinant Equine Interleukin-1 beta |
|||
P1394-.01 | ApexBio | 10ug | EUR 272.8 |
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Equine Interleukin-1 beta |
|||
P1394-.1 | ApexBio | 100ug | EUR 1405.6 |
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Equine Interleukin-1 beta |
|||
P1394-.5 | ApexBio | 500ug | EUR 3152.8 |
Description: Peptides & Proteins|Recombinant Proteins |
Equine IFN gamma Recombinant Protein |
|||
R00393-5 | BosterBio | 5ug/vial | EUR 310.8 |
Description: IFN-gamma, or type II interferon, is a cytokine that is critical for innate and adaptive immunity against viral and intracellular bacterial infections and for tumor control. Equine IFN gamma Recombinant Protein is purified IFN gamma produced in yeast. |
Nori Equine TNF RII/TNFRSF1B ELISA Kit |
|||
GR106481 | Genorise Scientific | 96-well | EUR 461 |
Genorise® Recombinant equine IL-2 |
|||
GR104002 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant equine IL-5 |
|||
GR104003 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant equine IL-6 |
|||
GR104004 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant equine IL-4 |
|||
GR104151 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant Equine IL-8 |
|||
GR104210 | Genorise Scientific | 5 µg | EUR 285 |
Equine Tumor Necrosis Factor Alpha (TNFa) ELISA Kit |
|||
DLR-TNFa-Eq | DL Develop | 96T | EUR 448 |
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Equine Tumor Necrosis Factor Alpha (TNFa) ELISA Kit |
|||
DLR-TNFa-Eq-48T | DL Develop | 48T | EUR 603.6 |
Description: A sandwich quantitative ELISA assay kit for detection of Equine Tumor Necrosis Factor Alpha (TNFa) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Equine Tumor Necrosis Factor Alpha (TNFa) ELISA Kit |
|||
DLR-TNFa-Eq-96T | DL Develop | 96T | EUR 784.8 |
Description: A sandwich quantitative ELISA assay kit for detection of Equine Tumor Necrosis Factor Alpha (TNFa) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Equine Tumor Necrosis Factor Alpha (TNFa) ELISA Kit |
|||
DL-TNFa-Eq | DL Develop | 96T | EUR 427 |
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Equine Tumor Necrosis Factor Alpha (TNFa) ELISA Kit |
|||
EK16991 | SAB | 96Т | EUR 768 |
Equine Tumor Necrosis Factor Alpha (TNFa) ELISA Kit |
|||
RDR-TNFa-Eq-48T | Reddot Biotech | 48T | EUR 459.38 |
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. |
Equine Tumor Necrosis Factor Alpha (TNFa) ELISA Kit |
|||
RDR-TNFa-Eq-48Tests | Reddot Biotech | 48 Tests | EUR 633.6 |
Equine Tumor Necrosis Factor Alpha (TNFa) ELISA Kit |
|||
RDR-TNFa-Eq-96T | Reddot Biotech | 96T | EUR 656.25 |
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. |
Equine Tumor Necrosis Factor Alpha (TNFa) ELISA Kit |
|||
RDR-TNFa-Eq-96Tests | Reddot Biotech | 96 Tests | EUR 879.6 |
Equine Tumor Necrosis Factor Alpha (TNFa) ELISA Kit |
|||
RD-TNFa-Eq-48T | Reddot Biotech | 48T | EUR 437.5 |
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. |
Equine Tumor Necrosis Factor Alpha (TNFa) ELISA Kit |
|||
RD-TNFa-Eq-48Tests | Reddot Biotech | 48 Tests | EUR 606 |
Equine Tumor Necrosis Factor Alpha (TNFa) ELISA Kit |
|||
RD-TNFa-Eq-96T | Reddot Biotech | 96T | EUR 625 |
Description: serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids. |
Equine Tumor Necrosis Factor Alpha (TNFa) ELISA Kit |
|||
RD-TNFa-Eq-96Tests | Reddot Biotech | 96 Tests | EUR 840 |
Equine Tumor Necrosis Factor Alpha (TNFa) ELISA Kit |
|||
MBS4502969-10x96Tests | MyBiosource | 10x96Tests | EUR 5115 |
Equine Tumor Necrosis Factor Alpha (TNFa) ELISA Kit |
|||
MBS4502969-48Tests | MyBiosource | 48Tests | EUR 445 |
Equine Tumor Necrosis Factor Alpha (TNFa) ELISA Kit |
|||
MBS4502969-5x96Tests | MyBiosource | 5x96Tests | EUR 2625 |
Equine Tumor Necrosis Factor Alpha (TNFa) ELISA Kit |
|||
MBS4502969-96Test | MyBiosource | 96Test | EUR 590 |
Genorise® Recombinant equine IL-1β |
|||
GR104001 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant equine IL-10 |
|||
GR104005 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant equine IL-12 |
|||
GR104006 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant equine IL-15 |
|||
GR104007 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant equine BMP-1 |
|||
GR104017 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant equine BMP-2 |
|||
GR104018 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant equine BMP-3 |
|||
GR104019 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant equine BMP-4 |
|||
GR104020 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant equine BMP-4 |
|||
GR104020-50 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant equine BMP-5 |
|||
GR104021 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant equine BMP-6 |
|||
GR104022 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant equine BMP-7 |
|||
GR104023 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant Equine IL-13 |
|||
GR104211 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant Equine sTNF RI |
|||
GR104214 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant Equine Osteopontin |
|||
GR104273 | Genorise Scientific | 5 µg | EUR 285 |
Nori Equine DOC2 alpha ELISA Kit |
|||
GR106554 | Genorise Scientific | 96-well | EUR 461 |
Interleukin-1 beta Equine Recombinant |
|||
rAP-0585 | Angio Proteomie | Inquiry | Ask for price |
Genorise® Recombinant equine BMP-8a |
|||
GR104024 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant Equine IL-1RA |
|||
GR104170 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant Equine sIL-2R |
|||
GR104212 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant Equine sIL-6R |
|||
GR104213 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant Equine sTNF RII |
|||
GR104220 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant Equine H-FABP |
|||
GR104286 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant Equine GM-CSF |
|||
GR104290 | Genorise Scientific | 5 µg | EUR 285 |
Recombinant equine serum amyloid A (SAA) |
|||
MBS664110-01mg | MyBiosource | 0.1mg | EUR 600 |
Recombinant equine serum amyloid A (SAA) |
|||
MBS664110-05mg | MyBiosource | 0.5mg | EUR 1045 |
Recombinant equine serum amyloid A (SAA) |
|||
MBS664110-1mg | MyBiosource | 1mg | EUR 1440 |
Recombinant equine serum amyloid A (SAA) |
|||
MBS664110-5x1mg | MyBiosource | 5x1mg | EUR 6145 |
Recombinant Equine Interleukin-2 Cys141Ser |
|||
AP60275 | SAB | 100ug | EUR 1398 |
Recombinant Equine Interleukin-2 Cys141Ser |
|||
P1396-.01 | ApexBio | 10ug | EUR 272.8 |
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Equine Interleukin-2 Cys141Ser |
|||
P1396-.1 | ApexBio | 100ug | EUR 1405.6 |
Description: Peptides & Proteins|Recombinant Proteins |
Recombinant Equine Interleukin-2 Cys141Ser |
|||
P1396-.5 | ApexBio | 500ug | EUR 3152.8 |
Description: Peptides & Proteins|Recombinant Proteins |
Genorise® Recombinant Equine PDGF-AA |
|||
GR104208 | Genorise Scientific | 5 µg | EUR 285 |
Genorise® Recombinant Equine PDGF-BB |
|||
GR104254 | Genorise Scientific | 5 µg | EUR 285 |
Recombinant Equine Interferon-gamma protein |
|||
CD02417-20ug | Jiaxing Korain Biotech Ltd (BT Labs) | 20ug | EUR 176 |
Interleukin-8, Recombinant, Equine (IL-8) |
|||
MBS638045-002mg | MyBiosource | 0.02mg | EUR 915 |
Interleukin-8, Recombinant, Equine (IL-8) |
|||
MBS638045-5x002mg | MyBiosource | 5x0.02mg | EUR 3955 |
Equine IL-1 beta Recombinant Protein |
|||
R00101-3 | BosterBio | 5ug/vial | EUR 310.8 |
Description: IL-1 beta (IL-1β) is a member of the interleukin 1 family of cytokines. The IL-1 beta cytokine is produced by activated macrophages as a proprotein, which is proteolytically processed to its active form by caspase 1 (CASP1/ICE). This cytokine is an important mediator of the inflammatory response, and is involved in a variety of cellular activities, including cell proliferation, differentiation, and apoptosis. Equine IL-1 beta Recombinant Protein is purified interleukin-1 beta cytokine produced in yeast. |
Equine IL-12 p40 Recombinant Protein |
|||
R01152-2 | BosterBio | 5ug/vial | EUR 310.8 |
Description: The IL-12 p40 subunit, or interleukin-12 beta subunit, is the 40 kD cytokine receptor-like subunit of the heterodimeric cytokines IL-12 and IL-23. IL-12 is involved in the differentiation of naive T cells into Th1 cells and the growth and function of T cells. Both IL-23 and IL-12 can activate the transcription activator STAT4 and stimulate the production of interferon-gamma (IFNG). Equine IL-12 p40 Recombinant Protein is purified interleukin-12 p40 produced in yeast. |
Melting of subducted sediments may clarify Ok-rich volcanic rocks which might be produced when the phlogopite pyroxenites soften throughout slab roll-back occasions. This course of can also assist constrain fashions for subduction zone seismicity. Since melts and phlogopite each have low frictional power, damaging thrust earthquakes are unlikely to happen within the neighborhood of the melting sediments, whereas elevated fluid pressures might promote the prevalence of small magnitude earthquakes and episodic tremor and slip.